The Discounted Cash Flow (DCF) valuation of Karo Pharma AB (KARO.ST) is 10.22 SEK. With the latest stock price at 60.30 SEK, the upside of Karo Pharma AB based on DCF is -83.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 6.7% | 5.9% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (7.99) - 278.97 | 10.22 |
| Upside | -113.3% - 362.6% | -83.1% |